Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Aug-23 2:23 PM View:  | Auerbach Mark Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 70,390 | -- | -- | (100%) 70.39K to 0 | |
| 31-Aug-23 2:45 PM View: | Lobell J Jay Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 200,000 | -- | -- | (15%) 1.36M to 1.16M | |
| 31-Aug-23 2:47 PM View: | Lopatin Uri A Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 351,948 | -- | -- | (100%) 351.95K to 0 | |
| 31-Aug-23 5:22 PM View: | Tananbaum James B. President and CEO Director 10% Owner | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition | 16,813,100 | -- | -- | (100%) 16.81M to 1.0K | |
| 31-Aug-23 2:41 PM View: | Henson Heidi Chief Financial Officer | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 316,753 | -- | -- | (100%) 316.75K to 0 | |
| 31-Aug-23 2:45 PM View: | Lobell J Jay Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 1,163,860 | -- | -- | (100%) 1.16M to 0 | |
| 31-Aug-23 2:54 PM View: | Varney Michael David Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 70,390 | -- | -- | (100%) 70.39K to 0 | |
| 31-Aug-23 5:22 PM View: | Tananbaum James B. President and CEO Director 10% Owner | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Acquisition (other) | 1,000 | -- | -- | < 1% 16.81M to 16.81M | |
| 31-Aug-23 2:44 PM View: | Lacy Elizabeth H. General Counsel, Secretary | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 211,169 | -- | -- | (100%) 211.17K to 0 | |
| 31-Aug-23 2:47 PM View: | Lopatin Uri A Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 5,327,800 | -- | -- | (94%) 5.68M to 351.95K | |
| 31-Aug-23 2:55 PM View: | Wiggans Thomas G Chief Executive Officer Director | Pardes Biosciences, Inc. (PRDS) | 31-Aug-23 | Disposition (change in control) | 50,000 | -- | -- | (100%) 50.0K to 0 | |
| 06-Apr-23 9:08 PM View: | Foresite Capital Management... 10% Owner | Pardes Biosciences, Inc. (PRDS) | 05-Apr-23 | Private Purchase | 773,952 | $1.50 | $1,160,930.00 | 6% 12.81M to 13.58M | |
| 06-Apr-23 9:08 PM View: | Foresite Capital Opportunit... 10% Owner | Pardes Biosciences, Inc. (PRDS) | 05-Apr-23 | Private Purchase Duplicate | 773,952 | $1.50 | $1,160,930.00 | 10% 8.0M to 8.77M | |
| 12-Dec-22 4:02 PM View: | Brusky Sean P. Chief Commercial Officer | Pardes Biosciences, Inc. (PRDS) | 08-Dec-22 | Private Purchase | 21,000 | $1.19 | $24,990.00 | 100% 0 to 21.0K | |
| 07-Dec-22 4:29 PM View: | Wiggans Thomas G Chief Executive Officer Director | Pardes Biosciences, Inc. (PRDS) | 05-Dec-22 | Private Purchase | 12,500 | $1.09 | $13,625.00 | 33% 37.5K to 50.0K | |
| 05-Dec-22 4:21 PM View: | Wiggans Thomas G Chief Executive Officer Director | Pardes Biosciences, Inc. (PRDS) | 02-Dec-22 | Purchase | 12,500 | $1.07 | $13,375.00 | 50% 25.0K to 37.5K | |
| 05-Dec-22 4:24 PM View: | Foresite Capital Management... 10% Owner | Pardes Biosciences, Inc. (PRDS) | 01-Dec-22 | Private Purchase | 637,420 | $0.85 | $541,807.00 | 5% 12.17M to 12.81M | |
| 05-Dec-22 4:21 PM View: | Wiggans Thomas G Chief Executive Officer Director | Pardes Biosciences, Inc. (PRDS) | 01-Dec-22 | Private Purchase | 25,000 | $1.04 | $26,000.00 | 100% 0 to 25.0K | |
| 21-Jul-22 4:16 PM View: | Lobell J Jay Director | Pardes Biosciences, Inc. (PRDS) | 19-Jul-22 | Acquisition (other) | 1,163,860 | -- | -- | 31% 3.79M to 4.96M | |
| 21-Jul-22 4:16 PM View: | Lobell J Jay Director | Pardes Biosciences, Inc. (PRDS) | 19-Jul-22 | Disposition (other) | 3,591,260 | -- | -- | (72%) 4.96M to 1.36M | |
| 21-Jul-22 4:16 PM View: | Lobell J Jay Director | Pardes Biosciences, Inc. (PRDS) | 19-Jul-22 | Acquisition (other) | 200,000 | -- | -- | 6% 3.59M to 3.79M | |
| 28-Dec-21 4:00 PM View: | Pakianathan Deepika Director | Pardes Biosciences, Inc. (PRDS) | 23-Dec-21 | Conversion | 52,500 | -- | -- | 100% 0 to 52.5K | |
| 28-Dec-21 4:00 PM View: | Dubin Daniel Director | Pardes Biosciences, Inc. (PRDS) | 23-Dec-21 | Conversion | 52,500 | -- | -- | 100% 0 to 52.5K | |
| 28-Dec-21 4:00 PM View: | Fs Development Holdings Ii,... 10% Owner | Pardes Biosciences, Inc. (PRDS) | 23-Dec-21 | Conversion | 4,873,750 | -- | -- | 809% 602.5K to 5.48M | |
| 28-Dec-21 4:30 PM View: | Tananbaum James B. Director 10% Owner | Pardes Biosciences, Inc. (PRDS) | 23-Dec-21 | Conversion Duplicate | 4,873,750 | -- | -- | 50% 9.69M to 14.56M | |
| 28-Dec-21 4:30 PM View: | Tananbaum James B. Director 10% Owner | Pardes Biosciences, Inc. (PRDS) | 23-Dec-21 | Grant | 8,759,070 | $1.14 | $10,000,000.00 | 944% 927.5K to 9.69M | |
| 28-Dec-21 4:00 PM View: | Hughes Owen Director | Pardes Biosciences, Inc. (PRDS) | 23-Dec-21 | Conversion | 52,500 | -- | -- | 100% 0 to 52.5K | |
| 23-Dec-21 4:52 PM View: | Tananbaum James B. Director 10% Owner | Pardes Biosciences, Inc. (PRDS) | 22-Dec-21 | Market Purchase | 325,000 | $10.00 | $3,250,000.00 | 100% 0 to 325.0K | 4% |
| 23-Feb-21 5:34 PM View: | Fs Development Holdings Ii,... 10% Owner | Pardes Biosciences, Inc. (PRDS) | 19-Feb-21 | Purchase | 602,500 | $10.00 | $6,025,000.00 | 100% 0 to 602.5K |
